Biomedical technology R&D can be expensive and take many years to reach commercialization, far beyond the budget provided in a standard Phase I and II SBIR/STTR grant. In response to this issue, NIH offers specific program announcements that allow for enhanced budgets and timelines for specific biomedical research activities (see below).
General Funding Announcements
- PA-12-088: PHS 2012-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- PA-12-089: PHS 2012-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Targeted Funding Announcements for SBIR and STTR Programs
| Title | SBIR Announcement Number |
|---|---|
| NIMH Small Business Innovation Research (SBIR, R44) Notice: Major Programmatic Priorities | NOT-MH-11-015 |
| Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44) | PA-11-133 |
| Competing Renewal Awards of SBIR Phase IIB Grants for Brain and Behavior Tools (R44) | PA-11-135 |
| Lab to Marketplace: Tools for Brain and Behavioral Research (SBIR [R43/R44]) | PA-11-134 |
| Bioengineering Nanotechnology Initiative (SBIR [R43/R44]) | PA-10-150 |
| Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (SBIR [R43/R44]) | PA-10-081 |
| Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44]) | PAR-09-220 |
| Clinical Neuroscience and Entertainment Software Pilot Partnership Program to Develop Neuropsychiatric Interventions (SBIR [R43/R44]) | RFA-MH-13-100 |
